GAIN THERAPEUTICS, INC Basic Shares Outstanding (Weighted Average)
GAIN THERAPEUTICS, INC (GANX) reported Basic Shares Outstanding (Weighted Average) of 42.88 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 42.88M shares, a 41.32% increase year-over-year.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 42.23M shares, a 47.22% increase year-over-year.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 37.82M shares, a 36.50% increase year-over-year.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 35.00M shares, a 31.91% increase year-over-year.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for fiscal 2025 was 32.97M shares, a 44.08% increase from fiscal 2024.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for fiscal 2024 was 22.88M shares, a 75.86% increase from fiscal 2023.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for fiscal 2023 was 13.01M shares, a 9.49% increase from fiscal 2022.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic for fiscal 2022 was 11.88M shares, a 16.90% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 42.88M shares 10-Q · filed 2026-08-11 | 42.56M shares 10-Q · filed 2026-08-11 | 40.98M shares derived: average of 3 quarters · filed 2026-08-11 | 39.48M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 42.23M shares 10-Q · filed 2026-05-11 | 40.02M shares derived: average of 2 quarters · filed 2026-05-11 | 38.35M shares derived: average of 3 quarters · filed 2026-05-11 | 36.35M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 37.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 36.41M shares derived: average of 2 quarters · filed 2026-03-26 | 34.39M shares derived: average of 3 quarters · filed 2026-08-11 | 32.97M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 35.00M shares 10-Q · filed 2025-11-12 | 32.67M shares derived: average of 2 quarters · filed 2026-08-11 | 31.35M shares 10-Q · filed 2025-11-12 | 30.43M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 30.34M shares 10-Q · filed 2026-08-11 | 29.52M shares 10-Q · filed 2026-08-11 | 28.91M shares derived: average of 3 quarters · filed 2026-08-11 | 28.32M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 28.69M shares 10-Q · filed 2026-05-11 | 28.20M shares derived: average of 2 quarters · filed 2026-05-11 | 27.64M shares derived: average of 3 quarters · filed 2026-05-11 | 25.53M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 27.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 27.12M shares derived: average of 2 quarters · filed 2026-03-26 | 24.48M shares derived: average of 3 quarters · filed 2026-03-26 | 22.88M shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 26.53M shares 10-Q · filed 2025-11-12 | 22.87M shares derived: average of 2 quarters · filed 2025-11-12 | 21.27M shares 10-Q · filed 2025-11-12 | 19.69M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 19.22M shares 10-Q · filed 2025-08-12 | 18.60M shares 10-Q · filed 2025-08-12 | 17.40M shares derived: average of 3 quarters · filed 2025-08-12 | 16.23M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 17.98M shares 10-Q · filed 2025-05-14 | 16.50M shares derived: average of 2 quarters · filed 2025-05-14 | 15.23M shares derived: average of 3 quarters · filed 2025-05-14 | 14.52M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 15.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 13.86M shares derived: average of 2 quarters · filed 2025-03-27 | 13.37M shares derived: average of 3 quarters · filed 2025-03-27 | 13.01M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 12.70M shares 10-Q · filed 2024-11-14 | 12.54M shares derived: average of 2 quarters · filed 2024-11-14 | 12.34M shares 10-Q · filed 2024-11-14 | 12.23M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 12.39M shares 10-Q · filed 2024-08-08 | 12.16M shares 10-Q · filed 2024-08-08 | 12.07M shares derived: average of 3 quarters · filed 2024-08-08 | 12.02M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 11.94M shares 10-Q · filed 2024-05-14 | 11.91M shares derived: average of 2 quarters · filed 2024-05-14 | 11.90M shares derived: average of 3 quarters · filed 2024-05-14 | 11.90M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 11.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 11.88M shares derived: average of 2 quarters · filed 2024-03-26 | 11.88M shares derived: average of 3 quarters · filed 2024-03-26 | 11.88M shares 10-K · filed 2024-03-26 |
| 2022-09-30 | 11.88M shares 10-Q · filed 2023-11-14 | 11.88M shares derived: average of 2 quarters · filed 2023-11-14 | 11.88M shares 10-Q · filed 2023-11-14 | 11.89M shares derived: average of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 11.88M shares 10-Q · filed 2023-08-10 | 11.88M shares 10-Q · filed 2023-08-10 | 11.89M shares derived: average of 3 quarters · filed 2023-08-10 | 11.89M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 11.88M shares 10-Q · filed 2023-05-12 | 11.89M shares derived: average of 2 quarters · filed 2023-05-12 | 11.89M shares derived: average of 3 quarters · filed 2023-05-12 | 11.88M shares derived: average of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | 11.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 11.89M shares derived: average of 2 quarters · filed 2023-03-23 | 11.88M shares derived: average of 3 quarters · filed 2023-03-23 | 10.17M shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 11.88M shares 10-Q · filed 2022-11-10 | 11.88M shares derived: average of 2 quarters · filed 2022-11-10 | 9.59M shares 10-Q · filed 2022-11-10 | 8.04M shares derived: average of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | 11.88M shares 10-Q · filed 2022-08-08 | 8.43M shares 10-Q · filed 2022-08-08 | 6.76M shares derived: average of 3 quarters · filed 2022-08-08 | 5.87M shares derived: average of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | 4.87M shares 10-Q · filed 2022-05-16 | 4.21M shares derived: average of 2 quarters · filed 2022-05-16 | 3.87M shares derived: average of 3 quarters · filed 2022-05-16 | 3.40M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | 3.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | 3.38M shares derived: average of 2 quarters · filed 2022-03-25 | 2.91M shares derived: average of 3 quarters · filed 2022-03-25 | 2.68M shares 10-K · filed 2022-03-25 |
| 2020-09-30 | 3.20M shares 10-Q · filed 2021-11-12 | 2.59M shares derived: average of 2 quarters · filed 2021-11-12 | 2.39M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 1.98M shares 10-Q · filed 2021-08-12 | 1.98M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |